نتایج جستجو برای: mdm2 snp309

تعداد نتایج: 4579  

Journal: :Blood 2010
Daniela Asslaber Josefina D Piñón Irina Seyfried Petra Desch Markus Stöcher Inge Tinhofer Alexander Egle Olaf Merkel Richard Greil

In chronic lymphocytic leukemia (B-CLL), aberrations along the p53 axis lead to decreased overall survival and therapy resistance. Recent studies identified microRNA-34a (miR-34a) as a major downstream target of p53. We monitored the expression of miR-34a during disease development in a murine B-CLL model. miR-34a was up-regulated more than 20-fold during the leukemic but not during the preleuk...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2007
Marta Sanchez-Carbayo Nicholas D Socci Thomas Kirchoff Nadina Erill Keneth Offit Bernard H Bochner Carlos Cordon-Cardo

PURPOSE The HDM2 gene represents one of the central nodes in the p53 pathway. A recent study reported the association of a single nucleotide polymorphism (SNP309) in the HDM2 promoter region with accelerated tumor formation in both hereditary and sporadic cancers. In this study, we aim to evaluate the SNP309 in bladder cancer and to link it to TP53 status. EXPERIMENTAL DESIGN SNP309 genotypin...

Journal: :Blood 2010
Yeon S Ahn

1. Zenz T, Krober A, Scherer K, et al. Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up. Blood. 2008;112(8): 3322-3329. 2. Malcikova J, Smardova J, Rocnova L, et al. Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on sur...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید